Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

The 2022 Tandem Meetings | Third-party virus-specific T-cells targeting 6 viruses post-BMT

Michael Keller • 23 Apr 2022
The 2022 Tandem Meetings
General

Michael Keller, MD, Children’s National Health System, Washington, DC, gives an overview of a study evaluating third-party virus-specific T-cells simultaneously targeting six different viruses following bone marrow transplantation (BMT). This interview took place at the Transplantation & Cellular Therapy (TCT) Meetings of ASTCT™ and CIBMTR® 2022 in Salt Lake City, Utah.

More from Michael Keller

1:56
Advances in off-the-shelf third-party T-cells for the treatment of infectious diseases post-BMT
Michael Keller • 23 Apr 2022
1:13
Third-party virus-specific T-cells for the treatment of refractory viral infections
Michael Keller • 24 Apr 2022

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals